Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3224)
All Articles published online
|
Apr 28, 2006 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | EL-Awady MK, Tabll AA, Atef K, Yousef SS, Omran MH, El-Abd Y, Bader-Eldin NG, Salem AM, Zohny SF, El-Garf WT. Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro. World J Gastroenterol 2006; 12(16): 2530-2535 [PMID: 16688798 DOI: 10.3748/wjg.v12.i16.2530] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i16/2530.htm |
| Number | Citing Articles |
| 1 |
Huma Tariq, Sobia Manzoor, Fahed Parvaiz, Farakh Javed, Kaneez Fatima, Ishtiaq Qadri. An overview: In vitro models of HCV replication in different cell cultures. Infection, Genetics and Evolution 2012; 12(1): 13 doi: 10.1016/j.meegid.2011.10.009
|
| 2 |
Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan Ball, Jean Dubuisson, Steven K.H. Foung, Arvind H. Patel, Mats A.A. Persson, Geert Leroux-Roels, Philip Meuleman. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. Virology 2018; 514: 30 doi: 10.1016/j.virol.2017.10.019
|
| 3 |
Sidra Rehman, Usman Ali Ashfaq, Bushra Ijaz, Sheikh Riazuddin. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells. Microbial Pathogenesis 2018; 121: 198 doi: 10.1016/j.micpath.2018.05.023
|
| 4 |
Asia Naz Awan, Rida Khalid, Aneela Javed, M. Raza Shah, Syed Abid Ali. Anti-Hepatitis C Virus (HCV) and Cytotoxic Activity of Sofosbuvir Decorated Dextran Stabilized Silver Nanoparticles. Plasmonics 2023; 18(3): 1181 doi: 10.1007/s11468-023-01817-w
|
| 5 |
Mohamed Abbas Shemis, Dina Mohamed El-Abd, Dalia Ibrahim Ramadan, Mohamed Ibrahim El-Sayed, Bassem Shenoda Guirgis, Mohamed Ali Saber, Hassan Mohamed El-Said Azzazy. Evaluation of Multiplex Nested Polymerase Chain Reaction for Routine Hepatitis C Virus Genotyping in Egyptian Patients. Hepatitis Monthly 2012; 12(4): 265 doi: 10.5812/hepatmon.6012
|
| 6 |
Noha Gamal Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa Khalil Ibrahim, Reham Mohamed Dawood, Naglaa Zayed, Yasmine S. El Abd, Reem El-Shenawy, Mostafa K. El Awady. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients. Journal of Interferon & Cytokine Research 2015; 35(8): 641 doi: 10.1089/jir.2014.0137
|
| 7 |
Imran Shahid, Waleed Hassan Almalki, Munjed M. Ibrahim, Sultan Ahmad Alghamdi, Mohammed H. Mukhtar, Shaia Saleh R. Almalki, Saad Ahmed Alkahtani, Mohammad S. Alhaidari. Characterization of In vitro Inhibitory Effects of Consensus Short Interference RNAs against Non-Structural 5B Gene of Hepatitis C Virus 1a Genotype. Indian Journal of Medical Microbiology 2018; 36(4): 494 doi: 10.4103/ijmm.IJMM_17_146
|
| 8 |
Noha G. Bader El Din, Sally Farouk. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research 2024; 44(6): 233 doi: 10.1089/jir.2024.0003
|
| 9 |
Ashraf A. Tabll, Samy B. Khalil, Reem M. El‐Shenawy, Gamal Esmat, Amr Helmy, Abdel Fattah Attallah, Mostafa K. El‐Awady. Establishment of Hybrid Cell Lines Producing Monoclonal Antibodies to a Synthetic Peptide from the E1 Region of the Hepatitis C Virus. Journal of Immunoassay and Immunochemistry 2007; 29(1): 91 doi: 10.1080/15321810701735161
|
| 10 |
Ryohei Saga, Akira Fujimoto, Noriyuki Watanabe, Mami Matsuda, Makoto Hasegawa, Koichi Watashi, Hideki Aizaki, Noriko Nakamura, Shigeru Tajima, Tomohiko Takasaki, Eiji Konishi, Takanobu Kato, Michinori Kohara, Haruko Takeyama, Takaji Wakita, Ryosuke Suzuki. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus. Scientific Reports 2016; 6(1) doi: 10.1038/srep28688
|
| 11 |
Yalin Liao, Esmail El-Fakkarany, Bo Lönnerdal, Elrashdy M. Redwan. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
Journal of Medical Microbiology
2012; 61(3): 375 doi: 10.1099/jmm.0.033894-0
|
| 12 |
Mostafa K El Awady, Mohamed A Anany, Gamal Esmat, Naglaa Zayed, Ashraf A Tabll, Amr Helmy, Abdel Rahman El Zayady, Mohga S Abdalla, Hayat M Sharada, Maissa El Raziky, Wafaa El Akel, Shadia Abdalla, Noha G Bader El Din. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy. Journal of Gastroenterology and Hepatology 2011; 26(5): 843 doi: 10.1111/j.1440-1746.2010.06605.x
|
| 13 |
Tawfeek H. Abdelhafez, Noha G. Bader El Din, Ashraf A. Tabll, Mohammad M. Mashaly, Reham M. Dawood, Nemat A. Yassin, Mostafa K. El-Awady. Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C Virus. Viral Immunology 2017; 30(5): 359 doi: 10.1089/vim.2016.0123
|
| 14 |
Sidra Rehman, Bushra Ijaz, Nighat Fatima, Syed Aun Muhammad, Sheikh Riazuddin. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study. Biomedicine & Pharmacotherapy 2016; 83: 881 doi: 10.1016/j.biopha.2016.08.002
|
| 15 |
Baptiste Jammart, Maud Michelet, Eve-Isabelle Pécheur, Romain Parent, Birke Bartosch, Fabien Zoulim, David Durantel. Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells. Journal of Virology 2013; 87(9): 5065 doi: 10.1128/JVI.01405-12
|
| 16 |
Elrashdy M Redwan, Esmail M EL-Fakharany, Vladimir N Uversky, Mustafa H Linjawi. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus. BMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-219
|
| 17 |
Maemu Petronella Gededzha, Maphahlanganye Jeffrey Mphahlele, Selokela Gloria Selabe. Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry Target. Hepatitis Monthly 2014; 14(11) doi: 10.5812/hepatmon.23660
|
| 18 |
Mariam Mounir, Marwa Khalil Ibrahim, Reham M. Dawood, Ahmed B. Barakat, Mostafa K. El Awady. Establishment of serum derived infectivity coculture model for enhancement of hepatitis C virus replication in vitro. Human Antibodies 2019; 27(3): 185 doi: 10.3233/HAB-190370
|
| 19 |
Faiza Shams, Shazia Rafique, Sadia Zahid, Mobeen Munir, Muhammad Idrees, Muhammad Ilyas, Tayyab Husnain. Advances in the role of HCV nonstructural protein 5a (NS5A) of 3a genotype in inducing insulin resistance by possible phosphorylation of AKT/PKB. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42602-2
|
| 20 |
Kai Deng, Zhanxue Xu, Mingxiao Chen, Xiaoxiang Liu, Enrique Ortega. Keyhole Limpet Hemocyanin-Conjugated Peptides from Hepatitis C Virus Glycoproteins Elicit Neutralizing Antibodies in BALB/c Mice. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/3108157
|
| 21 |
Koloko Brice Landry, Shafiq Azam, Sidra Rehman, Somayya Tariq, Bushra Iqbal, Mateen Abbas, Dieudonné Massoma Lembè, Bushra Ijaz. Phytochemical analysis of Berberis lyceum methanolic extract and its antiviral activity through the restoration of MAPK signaling pathway modulated by HCV NS5A. Asian Pacific Journal of Tropical Biomedicine 2021; 11(3): 132 doi: 10.4103/2221-1691.306133
|
| 22 |
Jinling Dong, Tiantian Wu, Ying Zhang, Zhihong Xie, Jie He. Transcriptome and MicroRNAs Profiling Analysis of Huh7.5.1 Cells in Response to Hepatitis C Virus Infection. Hepatitis Monthly 2021; 21(8) doi: 10.5812/hepatmon.118724
|
| 23 |
Jean-Christophe Meunier, Rodney S. Russell, Vera Goossens, Sofie Priem, Hugo Walter, Erik Depla, Ann Union, Kristina N. Faulk, Jens Bukh, Suzanne U. Emerson, Robert H. Purcell. Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus. Journal of Virology 2008; 82(2): 966 doi: 10.1128/JVI.01872-07
|
| 24 |
Mostafa K. El-Awady, Ashraf A. Tabll, Hassan Yousif, Yasmin El-Abd, Mohamed Reda, Samy B. Khalil, Abdel Rahman El-Zayadi, Maysa H. Shaker, Noha G. Bader El Din. Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus. Vaccine 2010; 28(52): 8338 doi: 10.1016/j.vaccine.2009.11.059
|